Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 8;15:2695–2713. doi: 10.2147/IJGM.S349925

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Li et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The relationship between the expression of different THOCs and clinicopathological parameters (UALCAN). (A) The relationship between the expression of different THOCs and individual cancer stages of HCC patients. THOCs mRNA expression levels were higher at the high cancer stage. (B) The relationship between the expression of different THOCs and tumor grades of HCC patients. With the increase of mRNA expression, their tumor grade tended to be higher. (C) The relationship between the expression of different THOCs and nodal metastasis status of HCC patients. N0; No regional lymph node metastasis, N1; Metastases in 1 to 3 axillary lymph nodes. *P < 0.05, **P < 0.01, ***P < 0.001.